Breast cancer
Conditions
Interventions
Group S:Sufentanil 3 µ g/kg was administered as a postoperative analgesic pump
Group O1:The postoperative analgesia pump was administered with oliceridine at a dose of 0.4mg/kg
Group O2:The postoperative analgesia pump was administered with oliceridine at a dose of 0.6mg/kg
Sponsors
Lu'an People's Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Female patients undergoing elective breast tumor surgery, the operation time is <=3h; 2. Age 40~65 years old; 3. ASA grade I.~II.; 4. Body mass index (BMI) <=30 kg/m^2; 5. After fully explaining the content of the clinical trial, voluntarily join and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Combined with serious diseases, such as abnormal liver and kidney function, abnormal lung function, severe cardiovascular and cerebrovascular diseases, etc.; 2. Those with poor control of diabetes and hypertension; Those who are suspected of having digestive system obstruction; 3. Those who have a history of motion sickness, severe nausea and vomiting, or use antiemetic drugs; 4. History of schizophrenia and other mental illnesses; Preoperative delirium or communication disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Visual Analog Scale (VAS) scores;Ramsay Sedation Scale scores ;Nausea and Vomiting; | — |
Countries
China
Contacts
Public ContactXiaodong Peng
Lu'an People's Hospital
Outcome results
None listed